Vistagen Therapeutics, Inc. (VTGN)

4.20 +0.25 (+6.33%) USD  |  NASDAQ  |  Dec 12, 11:48
More

Vistagen Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Omeros Corp. --
GeoVax Labs, Inc. Upgrade
Daré Bioscience, Inc. Upgrade